Periop HFNONCT07591610
Perioperative High-flow Nasal Oxygen in Patients Undergoing Robotic Surgery
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 5 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Enrolling by invitation only
- Study completion moved earlier from Oct 31, 2029 to Aug 3, 2029
- Start date changed from estimate of Nov 1, 2026 to Oct 30, 2026
- Site contact updated
- Minor Study description expanded, about 1 word
- Notable Start date: Aug 1, 2026 to Nov 1, 2026
- Eligibility criteria expanded, about 7 words
- Secondary endpoints: details revised at 1 of 3 entries
- Notable Primary endpoint(s) modified
- Secondary endpoints revised (3)
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (3)
Arms and interventions
In the control group, patients will receive standard of care anesthesia treatment, consisting of conventional preoxygenation and no active oxygen delivery during the apneic phase of induction. Following extubation, supplemental oxygen will be administered via face mask and subsequently weaned to standard nasal cannula as per routine clinical practice.
In the intervention group, patients will receive high-flow nasal oxygen starting from induction of anesthesia until intubation, and from extubation until discharge from PACU with weaning of high-flow nasal oxygen during their PACU stay.
Devices: High flow nasal oxygen
Sites
1 site in 1 country
- Beth Israel Deaconess Medical CenterBoston, Massachusetts, United States